Large Language Model platform for patient-friendly content

Topic:

Format:

AI-Driven De Novo Generation of Protein Binders

About the poster

The client aimed to develop a tool that will help patients to bridge the gap of understanding scientific language. The goal was not only to simplify complex content and streamline the workflow for specialists, but also to enhance the clarity and accessibility of health and medical knowledge. The project is designed to help patients better understand medical materials while enabling the organization to communicate in an open, clear, and modern way.

Our team has developed an AI-powered system that translates complex scientific documents into clear, patient-friendly language. The solution combines multiple approaches and utilizes Large Language Models (LLMs) to ensure accurate and understandable outputs.

Poster was presented at BioIT 2026 in Boston

You might be also interested in:

Biomedical knowledge graph connecting drug discovery data, disease biology, targets and indications to support target prioritization and indication expansion
Knowledge Graphs in Drug Discovery: Bringing Context to Internal Data Assets
Molecular structure representing AI-supported antibody design for blood-brain barrier research
How BBB-Penetrating Antibodies Cross the Blood-Brain Barrier
Life sciences conference takeaways 2026 - AACR, PEGS Boston, SLAS Europe, and Bio-IT World summary on AI in drug discovery
What 4 Life Sciences Conferences Revealed About AI in Drug Discovery
Life sciences professional using a tablet in front of digital data infrastructure screens
Scaling AI in Life Sciences: Why Data Infrastructure Determines Success

Contact

Ready to transform drug discovery?

Discover how one of the top AI CROs in the world, can be your trusted partner in revolutionizing drug discovery through AI.

Contact us today to learn more about our tailored solutions for empowering your drug development journey.

Send us a message and we will contact you back within 48 hours.

Newsletter

Become an insider

Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!